The carrier’s clinical basis for the SCS denial — that conservative care was inadequate — is factually incorrect on this record and the IRO correctly reversed it. The clinical record submitted with the PA request contained documentation of four post-surgical ESIs, two years of multi-modal pain management, a cleared psychological evaluation, and a board-certified pain physician’s clinical judgment that all conservative options had been exhausted. The plan UR physician’s denial applied an incorrect criteria threshold (requiring a specific number of PT sessions that the MCG criteria for SCS do not specify) and did not document review of the ESI records or the psychological evaluation. Three specific vulnerabilities exist in the denial that the plaintiff’s bad faith claim will exploit. This audit identifies each vulnerability and provides the remediation pathway for litigation defense. The carrier’s strongest defense argument is that the SCS trial criteria are legitimately complex and that the initial UR physician exercised clinical judgment in good faith — however, the same-basis Level 2 denial, after the member submitted additional documentation, is the most damaging element of the record for bad faith purposes.
The plan’s policy for SCS prior authorization incorporates MCG (Milliman Care Guidelines) criteria for Spinal Cord Stimulation. Each MCG criterion applicable to SCS trial authorization is evaluated against the documentation available to the UR physician at the time of the initial denial. This is the definitive test of whether the denial was clinically supportable — the fundamental question in a bad faith action.
| MCG criterion (SCS trial) | Met at submission? | Record evidence & UR physician review |
|---|---|---|
| Diagnosis consistent with SCS indication FBSS / post-surgical radiculopathy |
Met | Failed Back Surgery Syndrome following lumbar fusion is an MCG-listed primary indication for SCS. The diagnosis is unambiguously documented in the pain management records, the requesting physician’s letter, and the surgical records. The UR denial letter does not dispute the diagnosis. This criterion is met and not in dispute. |
| Documented failure of ≥6 months conservative care MCG criterion C-1 |
Met — 24 months | The member’s FBSS symptoms commenced with the index surgery in January 2023. The SCS PA was submitted in February 2025 — 24 months later. The pain management record documents continuous multi-modal pain management over this entire 24-month period. The UR denial letter states that “documentation does not demonstrate adequate trial of conservative therapies.” This statement is factually incorrect: the record submitted with the PA request includes 24 months of documented, continuous conservative management — four times the MCG minimum. The UR physician’s denial letter does not specify which conservative care element was allegedly missing. |
| Documented failure of ≥2 different drug classes for chronic pain MCG criterion C-2 |
Met | Medication record documents: gabapentin (adequate dose, 12 months, discontinued due to intolerance), duloxetine (adequate dose, 9 months, partial response), opioid analgesic (hydrocodone, per opioid management protocol, ongoing), NSAID trial (contraindicated after 3 months due to renal function), topical lidocaine (inadequate response). This is four distinct drug classes with documented failure or intolerance. MCG C-2 requires two. This criterion is clearly met. The UR denial does not reference medication history or invoke this criterion. |
| Documented failure of epidural steroid injections or interventional procedures MCG criterion C-3 |
Met — Not reviewed | Critical vulnerability. The submitted PA documentation includes records of four post-surgical lumbar ESIs (L4–L5 and L5–S1, two each) with documented inadequate response. The ESI records are included on pages 112–148 of the submitted PA package. The UR physician’s denial letter contains no reference to the ESI records. The UR file review log (internal document) does not list the ESI records as reviewed. MCG criterion C-3 requires documented failure of interventional procedures — this criterion is clearly met by the four ESI records, but there is no evidence the UR physician reviewed them. If the UR physician had reviewed the ESI records, the denial cannot be clinically sustained. If the UR physician did not review them, the denial was made on an incomplete clinical record. |
| Psychological evaluation clearance MCG criterion C-4 |
Met — Not reviewed | Critical vulnerability. MCG criterion C-4 requires a pre-SCS psychological evaluation confirming the absence of untreated psychiatric conditions that would preclude SCS candidacy. A psychological evaluation was performed by a licensed psychologist on January 15, 2025 and was included in the PA submission package (pages 201–218). The evaluation cleared the member for SCS implantation with no psychiatric contraindications. The UR denial letter does not reference the psychological evaluation. The UR file review log does not list the psychological evaluation as reviewed. The IRO reviewer specifically noted that the psychological evaluation clearance was present and adequate in the submission. |
| Requesting physician is appropriately specialized MCG criterion C-5 |
Met | The requesting physician is board-certified in Anesthesiology and Pain Medicine. MCG C-5 requires the SCS request to originate from a pain management specialist. Met. Not in dispute. |
| No contraindications present MCG criterion C-6 |
Met | No documented coagulopathy, active systemic infection, or active untreated psychiatric contraindication. The psychological evaluation specifically cleared this. Met. Not in dispute. |
All six MCG criteria applicable to SCS trial authorization were met by the documentation in the submitted PA package. The UR physician’s denial was based on a criteria element (inadequate conservative care) that is factually contradicted by the record. Most critically, the two criteria that are most specific to SCS authorization — the post-surgical interventional procedure failure (C-3, four ESIs) and the psychological evaluation clearance (C-4) — appear to not have been reviewed by the UR physician, as neither is referenced in the denial letter or the review log. The IRO’s reversal explicitly cited both the ESI records and the psychological evaluation as documenting met criteria. The bad faith plaintiff will frame this as the plan denying coverage without reviewing the most clinical significant documents in the submission.
A review of the UR physician’s documentation practices across the initial denial and both appeal levels. In a bad faith action, the quality of the UR physician’s documentation is the evidentiary foundation for the carrier’s defense. Inadequate documentation of the clinical rationale is itself evidence of an inadequate review process.
| Documentation element | Adequacy | Audit finding & bad faith relevance |
|---|---|---|
| UR physician’s review log | Deficient | The UR physician’s review log lists 7 of the 23 documents submitted with the PA request. The ESI records (pages 112–148) and the psychological evaluation (pages 201–218) are not listed. In a bad faith action, an incomplete review log is direct evidence that the UR physician did not review all submitted documentation before denying the request. The plaintiff will rely on this log as the central exhibit demonstrating incomplete review. |
| Denial letter clinical rationale | Deficient | The initial denial letter (March 14, 2025) is 1.5 pages. The clinical rationale section is a single paragraph: “The submitted documentation does not demonstrate an adequate trial of conservative therapies as required by plan medical policy. Specifically, the documentation does not establish the completion of a structured physical therapy program as a prerequisite to interventional device consideration.” This rationale: (1) does not reference any specific MCG criterion number; (2) invokes a “structured physical therapy program” requirement that does not appear in the MCG SCS criteria as a quantified minimum; (3) does not address the documented 24 months of conservative management; (4) does not address the four ESIs; and (5) does not address the psychological evaluation. A denial letter that fails to specify which criteria element was unmet and why is not a clinically adequate denial letter under standard UR documentation practice. |
| Level 1 appeal review | Deficient | The Level 1 appeal denial letter (April 8, 2025) is 1.2 pages and reproduces the identical clinical rationale as the initial denial, word for word, with a different date. The member’s Level 1 appeal submission included a 4-page letter from the requesting pain physician specifically responding to the PT program requirement and providing explicit documentation of the four ESIs and the psychological evaluation. The Level 1 appeal denial does not acknowledge any of the additional documentation provided in the appeal. An appeal denial that does not address new clinical information provided by the member is among the most damaging fact patterns in a bad faith action. |
| Level 2 appeal review | Partial | The Level 2 appeal was reviewed by a second UR physician (different from the initial reviewer). The Level 2 denial letter (May 3, 2025) is 2.5 pages and references the requesting physician’s appeal letter. It acknowledges the four ESIs but characterizes them as “not demonstrating systematic failure of the complete conservative care protocol.” The Level 2 denial does not specify what “complete conservative care protocol” requires beyond what is documented. It does not acknowledge the psychological evaluation. This is a partial improvement over Level 1 but still inadequate, and the IRO reversed on both the ESI adequacy assessment and the psychological evaluation acknowledgment gap. |
| Criteria version documentation | Gap | The denial letters reference “plan medical policy” and “MCG criteria” but do not specify the MCG criteria version applied. MCG SCS criteria are updated annually. In a bad faith action, the carrier must establish that the criteria applied were the most current version in effect at the time of the denial and that the criteria version applied is consistent with the plan’s adopted criteria schedule. The UR file does not contain documentation of which MCG version was used. |
An assessment of whether the UR process complied with applicable regulatory requirements (ACA, state UR laws, ERISA standards) and the plan’s own stated UR procedures. Process violations that are independent of the clinical merits create separate bad faith exposure and can be used by plaintiff to argue systemic rather than case-specific bad faith.
| Process standard | Compliance | Audit finding |
|---|---|---|
| Turnaround time — non-urgent PA ACA: 15 calendar days |
Compliant | PA submitted February 25, 2025. Denial issued March 14, 2025 (17 calendar days). The plan extended the review window by 14 days (within the ACA-permitted extension with member notice). The extension notice was sent on March 7, 2025 within the required timeframe. Turnaround time compliant. |
| Denial notice requirements ERISA §503, ACA |
Partial | The denial notice includes: the specific reason for denial, the plan criteria applied (by name, not by criterion number), the member’s right to appeal, and appeal timeframes. Missing: the denial does not include the specific clinical rationale in sufficient detail for the member to understand what additional documentation would result in approval. ERISA regulations and ACA implementing guidance require that denial notices be sufficiently specific to allow the member to perfect an appeal. The generic “adequate conservative care not documented” rationale without specifying which element is missing does not meet this standard. |
| UR physician specialty match State UR law / URAC standards |
Non-Compliant | Critical compliance gap. The initial denial UR physician is a board-certified internist. The request is for a spinal cord stimulator — an interventional pain procedure. Most state UR statutes (and URAC UR accreditation standards) require that a UR denial be issued by a physician in the same or similar specialty as the type of care under review when the denial is based on clinical criteria. A general internist reviewing an interventional pain procedure request for a complex chronic pain patient with post-surgical neuropathy does not meet the specialty-match standard. The Level 2 reviewer is a physiatrist — closer but still not an interventional pain specialist. This specialty-match deficiency is a documented process violation available to the plaintiff independent of the clinical merits argument. |
| Peer-to-peer opportunity URAC standard / plan policy |
Gap | The plan’s own UR policy (section 4.3) states that a peer-to-peer discussion opportunity will be offered to the requesting provider prior to adverse determination on complex clinical requests. The UR file contains no documentation that a peer-to-peer opportunity was offered to the requesting pain physician before the initial denial. The requesting physician’s appeal letter references not being offered a peer-to-peer call. If the plan’s own policy requires peer-to-peer and it was not offered, this is a plan policy violation independent of regulatory requirements. |
| IRO referral process ACA external review requirements |
Compliant | Following Level 2 denial, the member was notified of her right to external review within the required timeframe. The IRO was an appropriately accredited organization. The IRO process was compliant. The IRO reversal, however, becomes a highly damaging exhibit in the bad faith action because it is the opinion of a neutral clinical panel finding that the plan’s denial was incorrect — something the plaintiff will use to establish that the denial was not “fairly debatable.” |
The three specific vulnerabilities in this denial record that create the highest bad faith litigation exposure, ranked by expected plaintiff reliance and difficulty of defense rebuttal. Identified for carrier legal counsel and the medical director.
The plaintiff’s most powerful factual argument is that the Level 1 appeal denial reproduced the initial denial rationale word-for-word without acknowledging the requesting physician’s four-page appeal letter specifically documenting the ESIs and psychological evaluation. Under the “fairly debatable” standard used in most state bad faith law, a denial is not fairly debatable if the insurer fails to evaluate all information submitted. An appeal denial that does not acknowledge new information submitted on appeal is the strongest single indicator that the review process was perfunctory rather than substantive. This is the fact pattern plaintiff’s counsel will center the case on.
The UR physician’s review log documents review of 7 of 23 submitted documents and does not include the two most clinically significant documents in the submission — the four ESI records and the psychological clearance evaluation. The IRO reversal explicitly cited both as documentation of met criteria. The plaintiff will argue that a UR physician who denies a claim without reviewing the most clinically relevant documents in the submission did not conduct a meaningful review. This argument is difficult to rebut when the review log itself is the evidence.
The initial denial issued by a board-certified internist for a complex interventional pain request creates a process-based bad faith argument independent of the clinical analysis. The plaintiff will argue that a generalist internist reviewing a spinal cord stimulator request for a patient with failed spinal fusion and post-surgical neuropathy lacks the clinical background to assess whether conservative care failure was adequate. Most state UR statutes require specialty-matched review for denials of this type, and URAC standards are consistent with this requirement.
The carrier’s strongest defense argument is that SCS criteria genuinely require clinical judgment about adequacy of conservative care, that reasonable physicians can disagree about whether a specific conservative care course meets the criteria threshold, and that the UR process was conducted in good faith even if the ultimate determination was incorrect. The Level 2 denial by a physiatrist (a more appropriate specialty) who specifically engaged with the ESI records represents an improvement over the initial denial and supports the good-faith argument. The carrier should lean into this defense while remediating the Level 1 and review-log vulnerabilities.
A physician-authored narrative articulating the strongest clinically defensible rationale for the denial — a rationale that the original UR documentation failed to express but that may be arguable from the clinical record. This is the clinical argument that should be developed with the carrier’s retained medical expert. This narrative does not assert that the denial was correct — the IRO reversal establishes it was not. It identifies the most defensible clinical argument available to the carrier for bad faith purposes.
MCG SCS criteria require that the member demonstrate failure of “adequate” conservative care — a term that requires clinical judgment to apply. The plan’s UR physicians could argue that while the member documented four ESIs, the documentation submitted did not adequately specify the degree of functional improvement and subsequent functional decline following each injection. MCG criterion C-3 requires documentation that interventional procedures provided inadequate or unsustained relief — not merely that they were performed. The ESI records in the submission document the procedures and note “inadequate response” but do not include pre- and post-injection pain scores, functional outcome measures, or duration-of-relief documentation that would more robustly demonstrate inadequate response by clinical standards.
Additionally, the psychological evaluation clearance, while present, used a self-report instrument (BDI-II) without a structured clinical interview or full MMPI-2-RF administration — the more robust assessment protocol recommended in the SCS literature. A UR physician reviewing the psychological evaluation could have found it methodologically less comprehensive than MCG C-4 contemplates, though the MCG criteria do not specify the required assessment instruments.
The limitation of this defensive narrative is that these arguments were not articulated in the denial letters — they were not the basis on which the denial was made. In a bad faith action, the carrier typically cannot defend on clinical grounds that were not the basis of the original denial. The original denial said “adequate conservative care not documented.” It did not say “ESI outcome documentation was methodologically insufficient” or “psychological evaluation was incomplete.” Courts in most jurisdictions limit the carrier’s defense to the rationale stated in the denial letter. This is why the documentation deficiencies in Section 04 are so damaging — they limit the clinical arguments now available to the carrier in litigation.
Physician-authored recommendations for remediation of the UR process gaps identified in this audit. These recommendations address the systemic conditions that produced the vulnerabilities in this specific denial. Their implementation reduces the carrier’s bad faith exposure in future claims and may be relevant to demonstrating good-faith remedial action in the current litigation.
The UR review log should list every document submitted with the PA request by date, author, and document type, with a notation that each was reviewed. For complex clinical requests (>15 pages), a document inventory confirmation should be completed before the review is closed. The review log gap is the single most damaging process vulnerability in this record and is the easiest to remediate prospectively.
Appeal denial letters must demonstrate that the new information submitted with the appeal was reviewed and considered, even if the determination is unchanged. A template section heading “Response to Additional Clinical Information Submitted with Appeal” should be required in all appeal denial letters, with a brief specific narrative addressing the new documentation. The Level 1 denial that reproduced the initial denial word-for-word without acknowledging the requesting physician’s responsive letter is the most damaging single document in this litigation.
Create and enforce a specialty-match routing protocol requiring that PA requests for interventional procedures (SCS, intrathecal pump, ablation), surgical procedures, and complex device requests be routed to UR physicians with relevant specialty training. For SCS requests, the initial UR reviewer should be an interventional pain specialist, physiatrist, or neurosurgeon. An internist or family medicine physician is not an appropriate primary reviewer for a spinal cord stimulator request. This policy should be codified in the UR policies and procedures manual and tracked via the UR software routing logic.
The plan’s own policy (section 4.3) requires a peer-to-peer opportunity for complex clinical requests. Create a workflow checkpoint requiring documentation that: (1) the peer-to-peer opportunity was offered; (2) if accepted, the peer-to-peer discussion outcome was documented; (3) if declined, the declination was documented. The denial should not be finalized until this checkpoint is completed. The failure to offer or document a peer-to-peer call in this case is a plan policy violation that is independent of the regulatory bad faith argument.
Denial letters for MCG-criteria-based decisions should cite the specific MCG criterion number that was not met, specify the MCG edition/version applied, and provide a factual explanation of why the submitted documentation does not satisfy that specific criterion. Generic denial language (“adequate conservative care not documented”) without criterion-specific attribution is insufficiently specific to meet ACA adverse notice requirements and creates the ambiguity that made this denial vulnerable at appeal and IRO.
SCS is among the highest-risk PA categories for bad faith litigation because the criteria require nuanced clinical judgment and the procedure is high-cost with documented efficacy for FBSS. A targeted audit of recent SCS denials using the same MCG criterion-by-criterion framework applied in this report will identify whether the documentation and process deficiencies found here are systemic or case-specific — a critical distinction for both litigation defense and regulatory exposure management.